Myelodysplastic Syndrome / Chronic Myelomonocytic Leukemia

1 clinical trials · Condition

Record	Firm	Date
Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances (NCT05092451)	M.D. Anderson Cancer Center	2022-11-01

Every clearance here is in the API, with alerts when new ones post.